CHICAGO, Nov 11 (Reuters) - A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers ...

In a scant notice posted to its website on Wednesday, the European Medicines Agency (EMA) divulged that it has been hit by a cyberattack. While the agency did not reveal any details about the extent ...

Pfizer's deliberations, which previously have not been disclosed, offer a rare window into the frustrating search for Alzheimer's treatments inside one of the world's largest drug companies. Despite ...

CLAIM: A Pfizer document reveals that 82%-97% of pregnant women who received the company’s COVID-19 vaccine “lost their babies.” THE FACTS: The flawed calculation misrepresents a narrow subset of data ...

Regulatory Recon: Pfizer Weighs Sale of Consumer Health Business FDA Releases Briefing Documents for Spark Gene Therapy (10 October 2017) Welcome to Regulatory Reconnaissance, your daily regulatory ...